NanoString Blog

A discussion on advances in biomarker research
Illustration of a doctor looking at different cell structures

3D Biology™ Technology

Getting More from Flow Cytometry

Immunology studies rely on identifying unique cell populations, such as T cells and B cells, and then analyzing these cells to understand the biology of these cells. Studying different types…

Robin Lynn White / October 2, 2017
Checkpoint inhibitors

Digital Spatial Profiling Q&A

Characterizing Severe Autoimmune Toxicities Associated with Checkpoint Inhibitor Therapies

Immune checkpoint inhibitors (ICI) have emerged as powerful tools against cancer but in some cases have caused inflammation of organ systems that contributed to morbidity or mortality in patients. The…

Robin Lynn White / March 31, 2017
3d model of human internal organs


The IO Revolution, Part 3 of 4: The Role of the Tumor in the Cancer Immunity Cycle

Part one of this four-part series looked at how host, tumor, and environmental factors shape tumor-immune system interactions. Part two further examined the role of the host, and in this…

acesano / March 9, 2017
illustration of sequencing probes

Hyb & Seq™ Technology

Live sequencing with the Hyb & Seq™ platform at AGBT 2017

“We wanted to make the world’s simplest sequencer,” remarked Joe Beechem, Ph.D., Senior Vice President of R&D at NanoString. Beechem presented the Hyb & Seq platform with live demonstration during…

Robin Lynn White / February 24, 2017
Role of the host


The IO Revolution, Part 2 of 4: The Role of the Host in the Cancer Immunity Cycle

Part one of this four-part series looked at how host, tumor, and environmental factors shape tumor-immune system interactions. In the next few blogs, we will consider how each of these…

acesano / January 12, 2017
Colored scan of T lymphocytes and a cancer cell


Presidents, Rock Stars and Companion Diagnostics: 2016 Review of Immunotherapy

President Jimmy Carter announced this spring that he no longer needed treatments for the metastatic melanoma found in his brain–after treatment with pembrolizumab (Keytruda, Merck), his physicians could no longer…

acesano / January 7, 2017
Outside of the ASH 2016 venue


ASH 2016: Subtyping in Diffuse Large B-Cell Lymphoma

NanoString at ASH 2016. We attended the annual meeting of the American Society of Hematology (ASH) in San Diego. The convention center was abuzz with scientists…

acesano / January 4, 2017
Graphic of the Cancer Immunogram

Publication Watch

The Cancer Immunogram: A Picture of Personalized Medicine

What do we already know about tumor-immune system interactions, and how can this information be used to help guide us toward the best therapeutic choice? That is exactly the question…

acesano / December 27, 2016
Photo of the SITC 2016 entrance


SITC 2016 Recap

Looking beyond anti-PD1/PDL1 with combination therapy and gene signature testing

acesano / November 21, 2016
Illustration showing the immuno-oncology relationship


The IO Revolution, Part 1 of 4: Opportunities and Challenges

Immuno-oncology (IO) focuses on harnessing the tremendous power of the human immune system to detect and destroy cancer cells.

acesano / November 21, 2016